跳转至内容
Merck
CN

60441

高氯酸钾

puriss. p.a., ACS reagent, ≥99.0%

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
KClO4
化学文摘社编号:
分子量:
138.55
UNSPSC Code:
12352300
PubChem Substance ID:
EC Number:
231-912-9
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


grade

ACS reagent, puriss. p.a.

assay

≥99.0%

impurities

≤0.0005% total nitrogen (N)

pH

5.0-7.0 (25 °C, 1% in H2O)

mp

400 °C (dec.) (lit.)

anion traces

chloride (Cl-): ≤30 mg/kg, sulfate (SO42-): ≤10 mg/kg

cation traces

Ca: ≤10 mg/kg, Cd: ≤5 mg/kg, Co: ≤5 mg/kg, Cr: ≤5 mg/kg, Cu: ≤5 mg/kg, Fe: ≤5 mg/kg, Mg: ≤5 mg/kg, Mn: ≤5 mg/kg, Na: ≤50 mg/kg, Ni: ≤5 mg/kg, Pb: ≤5 mg/kg, Zn: ≤5 mg/kg

SMILES string

[K+].[O-]Cl(=O)(=O)=O

InChI

1S/ClHO4.K/c2-1(3,4)5;/h(H,2,3,4,5);/q;+1/p-1

InChI key

YLMGFJXSLBMXHK-UHFFFAOYSA-M

Other Notes

A -D suffix exists for administrative purposes only.
All -D packages are 100% the same product, same quality, same specification as the package sizes previously sold without a -D.



Still not finding the right product?

Explore all of our products under 高氯酸钾


pictograms

Flame over circleExclamation mark

signalword

Danger

hcodes

Hazard Classifications

Acute Tox. 4 Oral - Ox. Sol. 1

存储类别

5.1A - Strongly oxidizing hazardous materials

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type P3 (EN 143) respirator cartridges

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Y Hiasa et al.
Japanese journal of cancer research : Gann, 78(12), 1335-1340 (1987-12-01)
The effect of 1000 ppm potassium perchlorate (KClO4), 1000 ppm potassium iodide (KI) or 1000 ppm propylthiouracil (PTU) in the diet on the development of thyroid tumors was studied histologically and biochemically in Wistar rats given a single ip injection
G Coelho-Palermo Cunha et al.
Regulatory toxicology and pharmacology : RTP, 48(3), 270-278 (2007-06-19)
The perchlorate discharge assay (PDA) is potentially of high diagnostic value to distinguish between direct and indirect thyroid toxicity mechanisms, provided that standard treatment times are established and positive controls yield reproducible results. Therefore the PDA was evaluated after 2
F Bogazzi et al.
Journal of endocrinological investigation, 29(1), 61-66 (2006-03-24)
Amiodarone perturbs thyroid function, causing overt hypothyroidism or hyperthyroidism in 15% of patients. Changes in thyroid function are likely due, at least in part, to amiodarone and/or desethylamiodarone (DEA) concentration into the thyroid gland, but mechanisms whereby the drug uptake